Insider · CIK 0001577539
Gavin Wood
Files at ADAPY (Adaptimmune Therapeutics PLC). First filing Sep 3, 2025, latest Sep 3, 2025.
In brief
Gavin Wood files SEC Form 4 as CFO at ADAPY (Adaptimmune Therapeutics PLC). Since Sep 3, 2025, Gavin Wood has reported 0 open-market buys worth $0 and 1 open-market sell worth $950, the latest filed on Sep 3, 2025.
A track record needs three past buys with six months of prices behind them; Gavin Wood has 0, so none is measured yet.
The newest scored trade: sold $950 of ADAPY on Sep 2, 2025, filed Sep 3, 2025, scored 50 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ADAPY: Adaptimmune Therapeutics PLC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Adaptimmune Therapeutics PLC | $950 96,000 shares | -100% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 2, 2025 | ADAPY Adaptimmune Therapeutics plc | 16,000 0.01% of outstanding | $942 | Sep 2, 2025 | none |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | ADAPY Adaptimmune Therapeutics PLC | SOpen-market sale Ordinary Shares with a nominal value of GBP0.001 per share | -96,000 | $0.01 | $950 | 0 | Sep 3, 2025 |
Questions about Gavin Wood
Answered from the filings on this page, as of the latest one.
Is Gavin Wood buying or selling?
Not in the last 12 months. Gavin Wood's latest open-market trade on SEC Form 4 was sold $950 of ADAPY on Sep 2, 2025.
How did Gavin Wood's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gavin Wood has 0.
Where does Gavin Wood file Form 4?
Gavin Wood has filed Form 4 at ADAPY (Adaptimmune Therapeutics PLC) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.